These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21503566)

  • 1. Comparison of the protective effects of truncated bFGF and native bFGF against murine lung carcinoma.
    Luo Z; Peng X; Shi H; Gong C; Qian Z; Yang L
    Int J Mol Med; 2011 Jul; 28(1):3-8. PubMed ID: 21503566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel vaccine delivery system: biodegradable nanoparticles in thermosensitive hydrogel.
    Wu QJ; Zhu XC; Xiao X; Wang P; Xiong da K; Gong CY; Wang YS; Yang L; Wei YQ
    Growth Factors; 2011 Dec; 29(6):290-7. PubMed ID: 21981422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
    Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
    J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. bFGF peptide combined with the pVAX-8CpG plasmid as adjuvant is a novel anticancer vaccine inducing effective immune responses against Lewis lung carcinoma.
    Li M; Shi HS; Zhang HL; Luo ZC; Wan Y; Lu L; Luo ST; Yang L
    Mol Med Rep; 2012 Mar; 5(3):625-30. PubMed ID: 22200843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
    Pan JP; Weng YS; Wu QQ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src-family kinases.
    Yayon A; Ma YS; Safran M; Klagsbrun M; Halaban R
    Oncogene; 1997 Jun; 14(25):2999-3009. PubMed ID: 9223663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome.
    Xiao W; Chen X; Yang L; Mao Y; Wei Y; Chen L
    Int J Pharm; 2010 Jun; 393(1-2):119-26. PubMed ID: 20416367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
    Cai S; Liu Y; Zheng Shu X; Prestwich GD
    Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice.
    Bequet-Romero M; Ayala M; Acevedo BE; Rodríguez EG; Ocejo OL; Torrens I; Gavilondo JV
    Angiogenesis; 2007; 10(1):23-34. PubMed ID: 17273909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel liposomal vaccine improves humoral immunity and prevents tumor pulmonary metastasis in mice.
    Zhong Z; Wei X; Qi B; Xiao W; Yang L; Wei Y; Chen L
    Int J Pharm; 2010 Oct; 399(1-2):156-62. PubMed ID: 20692327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival.
    Shan S; Robson ND; Cao Y; Qiao T; Li CY; Kontos CD; Garcia-Blanco M; Dewhirst MW
    FASEB J; 2004 Feb; 18(2):326-8. PubMed ID: 14688196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: an export-dependent mechanism of action.
    Coltrini D; Gualandris A; Nelli EE; Parolini S; Molinari-Tosatti MP; Quarto N; Ziche M; Giavazzi R; Presta M
    Cancer Res; 1995 Oct; 55(20):4729-38. PubMed ID: 7553656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An N-, C-terminally truncated basic fibroblast growth factor and LPD (liposome-polycation-DNA) complexes elicits a protective immune response against murine colon carcinoma.
    Zhang XP; Yang L; Shi HS; Zhao X; Deng HX; Xiao WJ; Mao YQ; Kan B; Liu YL; Zhang S; Li ZM; Zhang J; Wei YQ
    Cancer Biol Ther; 2010 Aug; 10(3):276-81. PubMed ID: 20543584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel truncated basic fibroblast growth factor fragment-conjugated poly (ethylene glycol)-cholesterol amphiphilic polymeric drug delivery system for targeting to the FGFR-overexpressing tumor cells.
    Cai L; Qiu N; Li X; Luo K; Chen X; Yang L; He G; Wei Y; Chen L
    Int J Pharm; 2011 Apr; 408(1-2):173-82. PubMed ID: 21277964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitumor effect of recombinant T7 phage vaccine expressing xenogenic vascular endothelial growth factor on Lewis lung cancer in mice].
    Li XH; Tang L; Liu D; Sun HM; Zhou CC; Tan LS; Wang LP; Zhang PD; Zhang SQ
    Ai Zheng; 2006 Oct; 25(10):1221-6. PubMed ID: 17059764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.
    Jassar AS; Suzuki E; Kapoor V; Sun J; Silverberg MB; Cheung L; Burdick MD; Strieter RM; Ching LM; Kaiser LR; Albelda SM
    Cancer Res; 2005 Dec; 65(24):11752-61. PubMed ID: 16357188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable thermosensitive injectable PEG-PCL-PEG hydrogel for bFGF antigen delivery to improve humoral immunity.
    Gong CY; Shi S; Peng XY; Kan B; Yang L; Huang MJ; Luo F; Zhao X; Wei YQ; Qian ZY
    Growth Factors; 2009 Dec; 27(6):377-83. PubMed ID: 19919526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel vaccine adjuvant LPS-Hydrogel for truncated basic fibroblast growth factor to induce antitumor immunity.
    Shi HS; Gong CY; Zhang HL; Wang YS; Zhang J; Luo ZC; Qian ZY; Wei YQ; Yang L
    Carbohydr Polym; 2012 Aug; 89(4):1101-9. PubMed ID: 24750920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor.
    Hori A; Sasada R; Matsutani E; Naito K; Sakura Y; Fujita T; Kozai Y
    Cancer Res; 1991 Nov; 51(22):6180-4. PubMed ID: 1718597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.